Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Change in Accured Expenses (2023 - 2025)

Rallybio (RLYB) has disclosed Change in Accured Expenses for 3 consecutive years, with $33000.0 as the latest value for Q4 2025.

  • Quarterly Change in Accured Expenses rose 102.37% to $33000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.1 million through Dec 2025, up 65.64% year-over-year, with the annual reading at -$1.1 million for FY2025, 65.64% up from the prior year.
  • Change in Accured Expenses hit $33000.0 in Q4 2025 for Rallybio, up from -$350000.0 in the prior quarter.
  • In the past five years, Change in Accured Expenses ranged from a high of $1.6 million in Q2 2025 to a low of -$3.6 million in Q1 2023.
  • Historically, Change in Accured Expenses has averaged -$494666.7 across 3 years, with a median of -$158500.0 in 2025.
  • Biggest five-year swings in Change in Accured Expenses: crashed 316.01% in 2024 and later soared 2796.43% in 2025.
  • Year by year, Change in Accured Expenses stood at -$687000.0 in 2023, then tumbled by 102.77% to -$1.4 million in 2024, then soared by 102.37% to $33000.0 in 2025.
  • Business Quant data shows Change in Accured Expenses for RLYB at $33000.0 in Q4 2025, -$350000.0 in Q3 2025, and $1.6 million in Q2 2025.